DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Janjigian YY, Shitara K, Moehler M. et al.
First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial.
Lancet 2021;
398 (10294): 27-40
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.